NLM Logo

rilotumumab MeSH Supplementary Concept Data 2023


MeSH Supplementary
rilotumumab
Unique ID
C524459
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C524459
Entry Term(s)
AMG 102
AMG-102
AMG102
Pharm Action
Antineoplastic Agents, Immunological
Registry Number
51WEW898IJ
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
42
Note
a fully human monoclonal antibody that binds to hepatocyte growth factor (HGF), a potential cancer therapeutic agent because of its ability to disrupt HGF/c-Met signaling pathways which have been implicated in most tumor types
Source
Pharm Res 2007 Oct;24(10):1910-8
Date of Entry
2007/11/26
Revision Date
2019/11/01
rilotumumab Preferred
AMG 102 Narrower
page delivered in 0.007s